Clinical study of low-molecular-weight heparin calcium and aspirin therapy on acute cerebral infarction

OBJECTIVE To study the efficacy and safety of low-molecular-weight heparin calcium and aspirin on treating acute cerebral infarction.METHODS 240 cases with acute cerebral infarction were divided into four groups: the group treated with low-molecular-weight heparin calcium, the group treated with aspirin, the group treated with combined low-molecular-weight heparin calcium and aspirin and control group. The score of neurological defect scores, clinical effect and brain CT changes were observed before and after treatment. RESULTS The neurological defect scores and clinical effect of cases in three treatment groups were apparently better than those in control group,The neurological defect scores and clinical effects in the group treated with combined low-molecular-weight heparin calcium and aspirin were apparently better than those in the group treated with low-molecular-weight heparin calcium or aspirin. CONCLUSION The earlier treatment of acute cerebral infarction with low-molecular-weight heparin calcium and aspirin is safe and effective.